Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost

AI Summary

Leaders from the pharmaceutical industry are advocating for a rethinking of medical innovation as an investment rather than a cost amidst financial strains and health threats. Canada has also introduced new strategic investments aimed at supporting this shift.

Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […]